Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home    

Healthcare Market Research Reports

PRODUCT TITLE PUBLISHED
Asia Microbiology Asia Microbiology
Asian Microbiology market is growing in double digit and will continue to grow in future. China commanded the largest share 53% at an estimated $177.1 million in 2013 and is expected to reach $334.5 million by 2018, at a CAGR of 14.2% from 2013 to 2018. The report “Asian Microbiology Market forecast for 2018 “analyzes the market by two segments such as microbiology instruments and microbiology reagents.
Upcoming
North America Microbiology North America Microbiology
The Americas commanded the largest share 42% of the Global Microbiology Market at an estimated $1485.02 million in 2013 and are expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018. The report “North American Microbiology Market forecast for 2018 “analyzes the market by two segments such as instruments and reagents.
Upcoming
North American Microfluidics Market North American Microfluidics Market
The North American Microfluidics Market, mainly driven by rising incidences of diseases such as cancer, diabetes, infectious diseases, and cardiovascular diseases, brain disorders and sleep disorders which  was valued at $669 million in 2013 and is poised to grow at a CAGR of  17.4% to reach $1496 million by 2018. The Microfluidics market segmentation by type such as Polymer-based materials, glass-based materials, silicon-based materials, and other materials based Microfluidics. The main companies operating in this market and extensively covered in this report are Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences(Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.), Roche Diagnostics (Switzerland) and Siemens Healthcare (Germany)
Upcoming
European Microfluidics European Microfluidics
The European Microfluidics Market, mainly driven by rising incidences of diseases such as cancer, diabetes, infectious diseases, and cardiovascular diseases, brain disorders and sleep disorders which  was valued at $420 million in 2013 and is poised to grow at a CAGR of  15.2% to reach $852 million by 2018. The Microfluidics market segmentation by type such as Polymer-based materials, glass-based materials, silicon-based materials, and other materials based Microfluidics. The main companies operating in this market and extensively covered in this report are Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences(Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.), Roche Diagnostics (Switzerland) and Siemens Healthcare (Germany)
Upcoming
Asian Microfluidics Market Asian Microfluidics Market
The Asian Microfluidics Market, mainly driven by rising incidences of diseases such as cancer, diabetes, infectious diseases, and cardiovascular diseases, brain disorders and sleep disorders which was valued at $369 million in 2013 and is poised to grow at a CAGR of  20.9% to reach $952 million by 2018. The Microfluidics market segmentation by type such as Polymer-based materials, glass-based materials, silicon-based materials, and other materials based Microfluidics. The main companies operating in this market and extensively covered in this report are Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences(Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.), Roche Diagnostics (Switzerland) and Siemens Healthcare (Germany)
Upcoming
Europe Molecular Diagnostics Europe Molecular Diagnostics
Next to America, Europe holds second largest market position. Germany commanded the largest share 20% at an estimated $311.3 million in 2013 and is expected to reach $454.3 million by 2018, at a CAGR of 8.2% from 2013 to 2018. The report “European Molecular Diagnostics Market forecast for 2018 “analyzes the market by 2 segments such as instruments and reagents.  
Upcoming
Asia Molecular Diagnostics Asia Molecular Diagnostics
Asian Molecular Diagnostics market is growing in double digit and will continue to grow in future. China commanded the largest share 53% at an estimated $246.5 million in 2013 and is expected to reach $557.5 million by 2018, at a CAGR of 18.5% from 2013 to 2018. The report “Asian Molecular Diagnostics Market forecast for 2018 “analyzes the market by 2 segments such as instruments and reagents.
Upcoming
North America Molecular Diagnostics North America Molecular Diagnostics
The Americas commanded the largest share 42% of the Global Molecular Diagnostics Market at an estimated $2066.7 million in 2013 and are expected to reach $3221.4 million by 2018, at a CAGR of 9.7% from 2013 to 2018. The report “North American Molecular Diagnostics Market forecast for 2018 “analyzes the market by 2 segments such as instruments and reagents.
Upcoming
North American Bioinformatics North American Bioinformatics
The North American Bioinformatics Market, by increasing funding by government and private organization, was pegged at $1.36 billion in 2013 and expected to be $ 4.05 billion by 2018, growing at a CAGR of 20.1% from 2012 to 2018. The report “The North American Bioinformatics Market forecast, 2012-2018” analyzes the Bioinformatics market into Bioinformatics knowledge management, Bioinformatics services, Bioinformatics platforms. The report also provides an extensive competitive landscaping of companies operating in Bioinformatics market include Accelrys Inc., Affymetrix Inc., Life Technologies Corporation, Illumina Inc. and CLC bio.
Upcoming
North American Bio-MEMS Market North American Bio-MEMS Market
The North American  BIO-MEMS Devices Market, The usefulness of these devices is two-fold: for one, they improve medical device performance for the patient; and secondly, they offer competitive advantages to system manufacturers. BIO-MEMS market segmentation by Products such as DNA-Chips, Lab-on-chips, Drug delivery systems, Biosensors, Microfluidic Devices, Biomems implants, Silicon Microphones, Accelerometers, Gyroscopes, and microactuators .The main companies operating in Bio-Chips and BIO-MEMS Devices market and extensively covered in this report are Abbott, Baxter, Becton Dickinson(BD), Caliper Life sciences, Cepheid, Boston Scientific, Analog Devices, Bluechiip, CapitalBio, Dolomite, Medronic, Roche diagnostics, St. Jude Medical and others.
Upcoming
European Bio-MEMS Market European Bio-MEMS Market
The European  BIO-MEMS Devices Market, The usefulness of these devices is two-fold: for one, they improve medical device performance for the patient; and secondly, they offer competitive advantages to system manufacturers. BIO-MEMS market segmentation by Products such as DNA-Chips, Lab-on-chips, Drug delivery systems, Biosensors, Microfluidic Devices, Biomems implants, Silicon Microphones, Accelerometers, Gyroscopes, and microactuators .The main companies operating in Bio-Chips and BIO-MEMS Devices market and extensively covered in this report are Abbott, Baxter, Becton Dickinson(BD), Caliper Life sciences, Cepheid, Boston Scientific, Analog Devices, Bluechiip, CapitalBio, Dolomite, Medronic, Roche diagnostics, St. Jude Medical and others.
Upcoming
Asian Bio-MEMS Market Asian Bio-MEMS Market
The Asian BIO-MEMS Devices Market, The usefulness of these devices is two-fold: for one, they improve medical device performance for the patient; and secondly, they offer competitive advantages to system manufacturers. BIO-MEMS market segmentation by Products such as DNA-Chips, Lab-on-chips, Drug delivery systems, Biosensors, Microfluidic Devices, Biomems implants, Silicon Microphones, Accelerometers, Gyroscopes, and microactuators .The main companies operating in Bio-Chips and BIO-MEMS Devices market and extensively covered in this report are Abbott, Baxter, Becton Dickinson(BD), Caliper Life sciences, Cepheid, Boston Scientific, Analog Devices, Bluechiip, CapitalBio, Dolomite, Medronic, Roche diagnostics, St. Jude Medical and others.
Upcoming
European Bioinformatics European Bioinformatics
The European Bioinformatics Market, is driven by increasing funding by government and private organization, was pegged at $ 761 million in 2012 and expected to be $ 2.3 billion by 2018, growing at a CAGR of 19.7% from 2012 to 2018. Europe is the second largest leader of the market, due to rising Government support and funding. The report also provides an extensive competitive landscaping of companies operating in Bioinformatics market include Accelrys Inc., Affymetrix Inc., Life Technologies Corporation, Illumina Inc. and CLC bio.
Upcoming
Asia-Pacific Bioinformatics Asia-Pacific Bioinformatics
The Asia-Pacific Bioinformatics Market, is driven by increasing funding by government and private organization, was pegged at $ 580 million in 2012 and expected to be $ 2.19 billion by 2018, growing at a CAGR of 23.8% from 2012 to 2018. The report “The Asia-Pacific Bioinformatics Market forecast, 2012-2018” analyzes the Bioinformatics market into Bioinformatics knowledge management, Bioinformatics services, Bioinformatics platforms. The report also provides an extensive competitive landscaping of companies operating in Bioinformatics market include Accelrys Inc., Affymetrix Inc., Life Technologies Corporation, Illumina Inc. and CLC bio.
Upcoming
North America Radioimmunoassays (RIA) North America Radioimmunoassays (RIA)
The report “North American Radioimmunoassay (RIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. Radioimmunoassay accounted for about one-fifth of the share of the overall immunoassays market in 2013.
Upcoming
Asia-Pacific Radioimmunoassays (RIA) Asia-Pacific Radioimmunoassays (RIA)
Radioimmunoassay accounted for about one-third of the share of the overall immunoassays market in 2013. The report “Asia-Pacific Radioimmunoassay (RIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.
Upcoming
Europe Radioimmunoassays (RIA) Europe Radioimmunoassays (RIA)
Radioimmunoassay accounted for about one-fifth of the share of the overall immunoassays market in 2013. The report “European Radioimmunoassay (RIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.  
Upcoming
Asia Foot & Ankle Orthopedic Implants and Devices Asia Foot & Ankle Orthopedic Implants and Devices
The Asian foot & ankle implants and devices market is mainly driven by the aging population and the increasing prevalence of rheumatoid and osteoarthritis. The report analyzes the market of devices by 6 segments, namely, ankle fusion, total ankle replacement, sub-talar joint replacement, phalangeal implants, artificial tendons & ligaments, and musculoskeletal reinforcement. All the segments experienced a positive growth till 2012, owing to an increased awareness for procedures and sophisticated diagnostic techniques The report also provides an extensive competitive landscaping of the leading companies operating in this market. The key players in the Asian foot & ankle devices market are Wright Medical (U.S.), De Puy Synthes (U.S.), Arthrex (U.S.), Integra (U.S.), Tornier (U.S.), Stryker (U.S.),  Smith & Nephew (U.K.), Acumed (U.S.), Vilex (U.S.), Zimmer Holdings (U.S.), Biomet (U.S.), Bio-Pro (U.S.),  among a large number of niche players such as Ortho-fix (U.S.), Ortho-Helix (U.S.), Small Bone Innovations (U.S.), and Mondeal (U.K.).
Upcoming
North American Drug Delivery Devices Market North American Drug Delivery Devices Market
The North American Drug Delivery Devices Market was valued at $16 billion in 2013 and expected to be $110 billion by 2018, growing at a CAGR of 8.9%. The report “North American Drug Delivery Devices Market Forecast, 2012-2018“analyzes the market of Drug Delivery Devices by 9 technologies such as oral, transdermal, respiratory, injectable, implantable, transmucosal, nasal, ocular and topical drug delivery devices. The main companies operating in Drug Delivery Devices market and extensively covered in this report are SkyePharma Plc (U.K.), Ypsomed Holding AG (Switzerland), and GSK (U.K.).
Upcoming
European Drug Delivery Devices Market European Drug Delivery Devices Market
The European Drug Delivery Devices Market was valued at $45 billion in 2013 and expected to be $63 billion by 2018, growing at a CAGR of 8.3%. The report “European Drug Delivery Devices Market Forecast, 2012-2018“analyzes the market of Drug Delivery Devices by 9 technologies such as oral, transdermal, respiratory, injectable, implantable, transmucosal, nasal, ocular and topical drug delivery devices. The main companies operating in Drug Delivery Devices market and extensively covered in this report are SkyePharma Plc (U.K.), Ypsomed Holding AG (Switzerland), and GSK (U.K.).
Upcoming
2983 reports | Show
Connect With Us
US/CAN : +1-888-502-0539